Polymyxin E1 (Sulfate) contains a lipopeptide framework rich in cationic residues that promote membrane-binding investigations. Its cyclic-linear structural combination supports analysis of conformational rigidity. Researchers examine charge-driven interactions with lipid assemblies. Applications include microbial-peptide modeling, structural biophysics, and sequence-activity studies.
CAT No: R2703
CAS No:207990-63-4
Synonyms/Alias:Polymyxin E1 (sulfate);207990-63-4;
Polymyxin E1 (sulfate), also referred to as colistin E1 sulfate, is a cationic lipopeptide antibiotic derived from the bacterium Paenibacillus polymyxa. Known for its amphipathic structure, Polymyxin E1 (sulfate) exhibits strong affinity for the lipid A component of bacterial lipopolysaccharides, which underpins its notable activity against Gram-negative bacteria. The compound's sulfate form enhances its solubility in aqueous environments, making it suitable for a range of laboratory and research applications. Its unique interaction with bacterial membranes, leading to increased permeability and cell death, has made it an essential tool in microbiological studies and mechanistic investigations. Researchers value its robust activity profile and distinct mode of action, which sets it apart from other peptide-based agents.
Antimicrobial Mechanism Studies: In the field of antimicrobial research, colistin E1 sulfate is employed to elucidate the mechanisms underlying bacterial cell membrane disruption. By binding to the outer membrane of Gram-negative bacteria, it displaces divalent cations such as calcium and magnesium, which destabilizes the membrane structure and leads to increased permeability. This property makes it an indispensable agent for dissecting the molecular events associated with membrane perturbation, facilitating a deeper understanding of bacterial resistance pathways and the development of novel therapeutic strategies.
Membrane Permeabilization Assays: Polymyxin E1 (sulfate) is widely used in membrane permeabilization assays to assess the integrity of bacterial cell envelopes. Its ability to induce rapid leakage of intracellular contents serves as a reliable indicator of membrane compromise. Researchers utilize it to screen for membrane-active compounds, evaluate the synergistic effects of combination therapies, and optimize the design of next-generation antimicrobial agents. The reproducibility and specificity of its action make it a preferred standard in comparative studies.
Endotoxin Neutralization Research: In studies focused on endotoxin neutralization, colistin E1 sulfate is applied to investigate its capacity to bind and inactivate lipopolysaccharide (LPS) molecules. By directly interacting with the lipid A moiety of LPS, it reduces the biological activity of endotoxins, thereby serving as a model compound for exploring strategies to mitigate endotoxin-mediated responses in experimental systems. This application is particularly valuable in the context of sepsis research, where understanding LPS neutralization is critical.
Antibiotic Resistance Investigations: The rising prevalence of multidrug-resistant Gram-negative pathogens has prompted extensive use of Polymyxin E1 (sulfate) in resistance research. Scientists employ the compound to select for resistant bacterial strains, characterize resistance mechanisms, and assess the efficacy of resistance-modifying agents. Its role as a last-resort antimicrobial agent in laboratory models offers insights into adaptive bacterial responses and informs the development of novel countermeasures against resistant organisms.
Biofilm Disruption Studies: Polymyxin E1 (sulfate) is also instrumental in biofilm research, where it is used to evaluate its effects on established bacterial biofilms. By targeting the extracellular matrix and disrupting cell-to-cell interactions, it facilitates the study of biofilm architecture and resilience. Researchers leverage its activity to screen for compounds capable of enhancing biofilm eradication, providing a foundation for innovative approaches to combat persistent infections associated with biofilm formation.
Synergistic Antimicrobial Combinations: In addition to its standalone applications, colistin E1 sulfate is frequently investigated in combination with other antimicrobial agents to assess synergistic interactions. By pairing it with agents targeting different cellular processes, scientists can unravel the molecular basis of enhanced antibacterial efficacy and identify promising therapeutic combinations. These studies contribute to a broader understanding of combination therapy strategies and help address the global challenge of antimicrobial resistance. Through its multifaceted applications, Polymyxin E1 (sulfate) continues to serve as a cornerstone compound in microbiological and biochemical research, driving innovation and expanding knowledge in the field of infectious disease biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More